250 related articles for article (PubMed ID: 12955999)
1. Waldenstrom's macrogloblinaemia: modified plasmapheresis as treatment option in a Nigeria setting.
Abjah UM; Aken'Ova YA; Ocheni S
Niger J Med; 2002; 11(4):190-2. PubMed ID: 12955999
[TBL] [Abstract][Full Text] [Related]
2. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
[TBL] [Abstract][Full Text] [Related]
3. [Plasmapheresis in the treatment of waldenström's macroglobulinaemia (author's transl)].
Barbolla L; Fernández MN
Sangre (Barc); 1978; 23(3):334-42. PubMed ID: 97796
[No Abstract] [Full Text] [Related]
4. [Epistaxis and dizziness].
Hyttinen L
Duodecim; 2005; 121(9):1005, 1007. PubMed ID: 15991746
[No Abstract] [Full Text] [Related]
5. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
[TBL] [Abstract][Full Text] [Related]
6. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
[TBL] [Abstract][Full Text] [Related]
7. Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: a two-institution study.
Björkholm M; Johansson E; Papamichael D; Celsing F; Matthews J; Lister TA; Rohatiner AZ
Semin Oncol; 2003 Apr; 30(2):226-30. PubMed ID: 12720141
[TBL] [Abstract][Full Text] [Related]
8. Role of plasmapheresis in Waldenström's macroglobulinemia.
Stone MJ; Bogen SA
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):238-40. PubMed ID: 23522642
[TBL] [Abstract][Full Text] [Related]
9. Plasma exchange in the long-term management of Waldenström's macroglobulinemia.
Buskard NA; Galton DA; Goldman JM; Kohner EM; Grindle CF; Newman DL; Twinn KW; Lowenthal RM
Can Med Assoc J; 1977 Jul; 117(2):135-7. PubMed ID: 406031
[TBL] [Abstract][Full Text] [Related]
10. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
Menke MN; Feke GT; McMeel JW; Treon SP
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
[TBL] [Abstract][Full Text] [Related]
11. Hyperviscosity in plasma cell dyscrasias.
Kwaan HC
Clin Hemorheol Microcirc; 2013; 55(1):75-83. PubMed ID: 23455837
[TBL] [Abstract][Full Text] [Related]
12. Hyperviscosity syndrome in plasma cell dyscrasias.
Mehta J; Singhal S
Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
[TBL] [Abstract][Full Text] [Related]
13. [A case of small cell lung cancer with Waldenstrom's macroglobulinemia].
Nakayama Y; Natsuaki M; Itoh T; Nishioka K
Nihon Kyobu Geka Gakkai Zasshi; 1992 Jun; 40(6):1021-4. PubMed ID: 1321869
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of therapeutic procedure for Waldenström's macroglobulinemia with hyperviscosity syndrome.
Ito K; Kawasaki T; Hirano K; Sekiguchi N
Ther Apher Dial; 2024 Jun; 28(3):417-423. PubMed ID: 38069574
[TBL] [Abstract][Full Text] [Related]
15. Histidine based adsorbents for selective removal of monoclonal immunoglobulin IgM antibodies from Waldenstrom's macroglobulinemia patient sera: a preliminary study.
Srour M; Kassab I; Matta H; Elkak A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():1-5. PubMed ID: 23811496
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials Group.
Chen CI; Kouroukis CT; White D; Voralia M; Stadtmauer E; Stewart AK; Wright JJ; Powers J; Walsh W; Eisenhauer E;
J Clin Oncol; 2007 Apr; 25(12):1570-5. PubMed ID: 17353550
[TBL] [Abstract][Full Text] [Related]
17. [Hyperviscosity syndrome, macroglobulinemia].
Hatta Y; Sawada U
Nihon Rinsho; 2004 May; 62 Suppl 5():550-3. PubMed ID: 15197982
[No Abstract] [Full Text] [Related]
18. How we treat Waldenström's macroglobulinemia.
Dimopoulos MA; Merlini G; Leblond V; Anagnostopoulos A; Alexanian R
Haematologica; 2005 Jan; 90(1):117-25. PubMed ID: 15642678
[TBL] [Abstract][Full Text] [Related]
19. The use of emergency apheresis in the management of plasma cell disorders.
Kalayoglu-Besisik S
Transfus Apher Sci; 2018 Feb; 57(1):35-39. PubMed ID: 29477943
[TBL] [Abstract][Full Text] [Related]
20. Hyperviscosity syndrome in Waldenström's macroglobulinemia.
Krol TC; Wood WS
Am Fam Physician; 1981 Aug; 24(2):187-9. PubMed ID: 6789661
[No Abstract] [Full Text] [Related]
[Next] [New Search]